Skip to content

US · CYRX · INTEGRATED FREIGHT & LOGISTICS

Cryoport, Inc. (CYRX) intrinsic value and stock valuation

$19.05as of 2026-11-21 · Mkt cap 768.64M

Data updated · price as of 2026-11-21

Fairly valuedIC value is within 20% of the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Cryoport, Inc. DCF and intrinsic value

InvestorsCraft values CYRX with the Chepakovich two-stage DCF model — currently rated fairly valued. How the model works · Run your own DCF prefilled from CYRX’s statements →

Cryoport, Inc. Graham Number

Graham Number: $18.79d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Industrials · Integrated Freight & Logistics Brentwood, TN 37027 cryoportinc.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$176.2M+17.5% 5y CAGRd
20112025
Net income
$78.3M
20112025
Free cash flow
-$-28.09M
20112025
Total equity
$502.6M+5.6% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$176.2M$233.3M$237.3M$222.6M$222.6M
Operating income-$-36.81M-$-115.16M-$-31.9M-$-17.83M-$-17.83M
Net income$78.3M-$-99.59M-$-37.33M-$-275.53M-$-275.53M
EPSd$1.56M-$-2.04M-$-761.99K-$-6M-$-6M
Operating cash flow-$-8.58M-$-16.32M-$-760K-$-1.85M$8.13M
Capital expenditure-$-19.5M-$-17.25M-$-44.9M-$-24.2M-$-25.01M
Free cash flow-$-28.09M-$-33.58M-$-45.66M-$-26.05M-$-16.88M
Total assets$765M$703.5M$957.7M$1.04B$1.11B
Total debt$230.7M$250.7M$416M$435.9M$427.1M
Net debt-$-19.78M$205.4M$369.7M$399.3M$288M
Total equity$502.6M$401.9M$489M$555.8M$641.8M
Cash and short-term investments$411.2M$261.8M$456.8M$523.3M$628.8M
Income statement
20252024202320222021
Revenue$176.2M$233.3M$237.3M$222.6M$222.6M
Cost of revenue$93.1M$133.9M$133.4M$126M$126M
Gross profit$83.1M$99.3M$103.9M$96.6M$96.6M
Research and development expenses$17M$18M$15.7M$16.8M$16.8M
Selling, general and administrative expenses$102.8M$146.9M$120.1M$97.6M$97.6M
Other expenses$0.00$49.6M$0.00$0.00$0.00
Operating expenses$119.9M$214.5M$135.8M$114.4M$114.4M
Cost and expenses$213M$348.4M$269.2M$240.4M$240.4M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$2.36M$5.5M$6.14M$4.69M$4.69M
Depreciation and amortization$27.7M$27.5M$22.8M$20.3M$20.3M
Ebitda-$-2.1M-$-66.36M-$-6.19M-$-248.91M-$-248.91M
Operating income-$-36.81M-$-115.16M-$-31.9M-$-17.83M-$-17.83M
Total other income/expenses, net$4.64M$15.8M-$-3.19M-$-256.01M-$-256.01M
Income before tax-$-32.17M-$-99.35M-$-35.09M-$-273.84M-$-273.84M
Income tax expense$1.8M$240K$2.24M$1.69M$1.69M
Net income$78.3M-$-99.59M-$-37.33M-$-275.53M-$-275.53M
Weighted average shares outstanding$50.1M$48.7M$49M$45.9M$45.9M
Weighted average diluted shares outstanding$50.1M$48.7M$49M$45.9M$45.9M
Balance sheet
20252024202320222021
Cash and short-term investments$411.2M$261.8M$456.8M$523.3M$628.8M
Net receivables$33.4M$45.8M$42.1M$43.9M$39.4M
Inventory$23.2M$22.5M$26.2M$27.7M$16.5M
Total current assets$476.2M$341.6M$535.1M$604.2M$693.5M
Property, plant and equipment, net$125.2M$136M$117.5M$90.5M$69.7M
Goodwill and intangible assets$160.5M$222.1M$302.8M$342.1M$348.4M
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$288.8M$361.9M$422.6M$434.6M$419.5M
Total assets$765M$703.5M$957.7M$1.04B$1.11B
Accounts payable$15.3M$26.2M$26.1M$27.1M$28.6M
Short-term debt$189.8M$20.4M$5.81M$3.91M$3.6M
Deferred revenue$940K$1.11M$1.31M$440K$550K
Total current liabilities$219M$64.6M$45.6M$40.9M$42.7M
Long-term debt$40.9M$230.4M$410.2M$432M$423.5M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$43.3M$237M$423.1M$442.1M$428.5M
Capital lease obligations$44.4M$51.2M$36M$28.8M$21.8M
Total liabilities$262.4M$301.6M$468.7M$482.9M$471.1M
Common stock$50K$50K$50K$50K$50K
Retained earnings-$-688.88M-$-757.17M-$-642.42M-$-542.83M-$-467.54M
Accumulated other comprehensive income (loss)-$-3.48M-$-20.93M-$-26.07M-$-34.55M-$-1.24M
Total equity$502.6M$401.9M$489M$555.8M$641.8M
Total investments$160.7M$216.5M$410.4M$486.7M$489.7M
Total debt$230.7M$250.7M$416M$435.9M$427.1M
Net debt-$-19.78M$205.4M$369.7M$399.3M$288M
Cash flow statement
20252024202320222021
Net income$78.3M-$-114.76M-$-99.59M-$-37.33M-$-275.53M
Depreciation and amortization$27.7M$30.8M$27.5M$22.8M$20.3M
Stock-based compensation$11M$19.7M$22.8M$20.1M$15.4M
Change in working capital-$-13.69M-$-8.61M$780K-$-32.07M-$-6.96M
Accounts receivable-$-6.53M-$-4.15M$3.67M-$-4.14M-$-7.27M
Inventory-$-2.19M$3.25M$1.51M-$-14.2M-$-5.98M
Accounts payable-$-3.46M-$-80K-$-2.77M-$-6.48M$2.87M
Net cash provided by operating activities-$-8.58M-$-16.32M-$-760K-$-1.85M$8.13M
Investments in property, plant and equipment-$-16.44M-$-17.25M-$-38.78M-$-22.11M-$-23.88M
Acquisitions, net$210.2M$0.00-$-7.34M-$-6.55M-$-5.54M
Net cash used for investing activities$250.3M$176.8M$36.1M-$-59.68M-$-469.25M
Common stock issued$3.97M$2.79M$1.48M$2.05M$527.7M
Common stock repurchased-$-10.01M$0.00$0.00-$-37.96M$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities-$-21.07M-$-161.53M-$-23.8M-$-39.17M$564.3M
Net change in cash$205.2M-$-1.06M$9.75M-$-102.51M$102.2M
Cash at end of period$250.5M$45.3M$46.4M$36.6M$139.1M
Operating cash flow-$-8.58M-$-16.32M-$-760K-$-1.85M$8.13M
Capital expenditure-$-19.5M-$-17.25M-$-44.9M-$-24.2M-$-25.01M
Free cash flow-$-28.09M-$-33.58M-$-45.66M-$-26.05M-$-16.88M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Cryoport, Inc.

        Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.

        CEO
        Jerrell W. Shelton
        Employees
        688
        Beta
        1.89

        Explore

        Frequently asked questions

        What is the intrinsic value of Cryoport, Inc. (CYRX)?

        Cryoport, Inc. (CYRX) is currently fairly valued based on the InvestorsCraft IC model — IC value is within 20% of the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is CYRX undervalued?

        CYRX trades at a price of $19.05 (Nov 21, 2026): fairly valued — IC value is within 20% of the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.